Chime Financial (CHYM) Stock Climbs +50.8% in 30 Days After Earnings Surprise
Key Takeaways
- CHYM rose about 50.8% over the past 30 days, from a closing price of $20.95 on July 13, 2026, to $31.60 on August 12, 2026.
- The advance was driven primarily by Chime's second-quarter 2026 earnings beat, a second consecutive GAAP profit, and raised full-year revenue guidance.
- Shares jumped 20.6% on August 6, 2026, closing at $31.25 on volume of roughly 19.3 million shares, well above typical sessions.
- Over the trailing three months, CHYM has climbed about 76.7%, from $17.88 on May 14, 2026, to $31.60 on August 12, 2026.
- Several analysts raised price targets after the report, with post-earnings targets ranging from $28 to $45.
Chime Financial (CHYM) Company Overview and Market Position
Chime Financial, Inc. is a U.S.-based financial technology company that provides digital consumer banking and payment solutions. Its product ecosystem includes spending accounts, debit and credit cards, savings products, fee-free overdraft through SpotMe, the MyPay earned wage access service, Instant Loans, and the Chime Prime membership tier introduced in April 2026. In July 2026, the company launched Chime Invest, adding managed portfolios and self-directed brokerage to its app. Chime also operates a workplace banking unit, Chime Enterprise, which offers financial wellness tools and earned wage access to employers.
Chime's business model monetizes primary-account relationships through interchange, transaction fees, subscription revenue, and credit products. The company emphasizes its proprietary ChimeCore platform, which processes transactions and maintains ledgers internally to keep cost-to-serve low. Management cited a cost-to-serve of about $141 per customer, versus roughly $450 for large banks. In May 2026 survey data highlighted by the company, Chime captured about 14% of new checking account openings, and active members reached 10.4 million in the second quarter, up 20% year over year. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
CHYM Stock Price Performance: Last 30 Days vs. Quarter
From a closing price of $20.95 on July 13, 2026, CHYM advanced to $31.60 by the August 12, 2026 close, a gain of about 50.8% over 30 days. The move accelerated sharply after the August 5 earnings report: the stock closed at $25.92 on August 5 and then at $31.25 on August 6, a one-session gain of 20.6%. Intraday trading on August 6 reached $33.41, marking a 52-week high. After that spike, shares consolidated and closed at $31.60 on August 12, down 0.41% for the session.
The quarterly picture is even stronger. Three months earlier, on May 14, 2026, the stock closed at $17.88. The rise to $31.60 represents a gain of about 76.7%. The quarter was not a straight line: CHYM traded below $17 during parts of May and set a 52-week low of $15.88 on June 11 before recovering through late June and July and then breaking out on the earnings release.
What Drove CHYM Stock Price in the Last 30 Days
The primary catalyst was Chime's second-quarter 2026 results, reported on August 5. Revenue reached $669.8 million, up 26.8% year over year and above consensus estimates near $640.6 million. Adjusted EPS of $0.07 beat the consensus estimate of a $0.01 loss. GAAP net income was $28 million, the company's second consecutive quarter of positive GAAP earnings, and adjusted EBITDA reached $102 million, with the margin expanding to 15% from about 3% a year earlier.
Other operating metrics reinforced the story. Active members rose 20% year over year to 10.4 million, average revenue per active member increased 6% to $260, and transaction profit grew 36% to $492 million. MyPay originations totaled $4.5 billion with a loss rate of about 0.9%, while Instant Loan originations rose nearly 70% sequentially to $300 million. Management raised full-year revenue guidance to between $2.725 billion and $2.745 billion and announced a 10% workforce reduction intended to support operating leverage.
Analyst reaction amplified the move. Multiple firms raised price targets after the report, including Canaccord Genuity to $45, Evercore ISI to $39, B. Riley to $37, and several others to between $32 and $35. The overall consensus remained a Moderate Buy, but the revisions signaled rising confidence in Chime's profitability trajectory. Enterprise wins, including a workplace banking agreement with Allied Universal and a national retailer, and the July launch of Chime Invest added to the growth narrative. Some executives also disclosed stock sales under pre-arranged Rule 10b5-1 plans during the post-earnings strength, which added supply but did not reverse the advance.
What Drove CHYM Stock Performance Over the Last Quarter
The broader three-month trend reflects a shift in how investors are valuing Chime: from a high-growth, cash-burning fintech toward a business demonstrating repeatable profitability. The April launch of Chime Prime, aimed at higher-income members with at least $3,000 in monthly direct deposits, became a central growth driver. Management said Prime members generate more than twice the revenue per active member of the average member. Meanwhile, MyPay and Instant Loans scaled with disciplined loss rates, supporting transaction-margin expansion.
During May and early June, the stock was under pressure, touching a 52-week low of $15.88 on June 11. Sentiment improved through the summer as enterprise partnerships were announced, Chime Invest launched, and Wall Street began raising targets. The August earnings report then confirmed the operating leverage story, producing the sharp re-rating that pushed the trailing-quarter gain to roughly 77%.
CHYM Stock Forecast Drivers: What Investors Should Watch Next
Investors monitoring CHYM should track the rollout of new products and the sustainability of the profitability inflection. Chime said it expects Instant Loans to exit the third quarter at an annualized revenue run rate above $100 million and plans to begin beta testing a revolving line of credit for Prime members. Management also began raising MyPay limits to as much as $1,000, which could modestly lift loss rates even as transaction profit rises. Sell-side estimates have pointed to full-year EPS of about $0.34 for 2026.
Macroeconomic conditions and consumer spending trends remain important, given Chime's reliance on interchange and transaction activity. Competitive pressure from other digital banking and fintech platforms, the pace of Chime Prime adoption, rewards costs, and execution of the ChimeCore migration will also influence sentiment. After the sharp run, valuation and insider 10b5-1 selling plans may attract more scrutiny, while analyst estimates will be updated as the company reports subsequent quarters. From what I see, these factors will shape the next leg of the move.
Exploring AI Tools for Trading Insights
I often review Tickeron’s Trending AI Robots page when analyzing names like CHYM. It offers a curated view of AI-driven bots across many tickers, helping compare strategies, timeframes, and risk profiles without focusing on just one approach. This fits naturally into my research process for understanding automated options alongside fundamental developments.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
CHYM's MACD Histogram just turned positive
The Moving Average Convergence Divergence (MACD) for CHYM turned positive on July 31, 2026. Looking at past instances where CHYM's MACD turned positive, the stock continued to rise in of 7 cases over the following month. The odds of a continued upward trend are .
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on July 27, 2026. You may want to consider a long position or call options on CHYM as a result. In of 18 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CHYM advanced for three days, in of 52 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 29 cases where CHYM Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
Bearish Trend Analysis
The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 9 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CHYM declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
CHYM broke above its upper Bollinger Band on August 03, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CHYM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.518) is normal, around the industry mean (28.479). P/E Ratio (5.886) is within average values for comparable stocks, (81.364). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.725). Dividend Yield (0.000) settles around the average of (0.048) among similar stocks. P/S Ratio (4.973) is also within normal values, averaging (69.517).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CHYM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
Advertisement